Key Takeaways
- • The Delaware Court of Chancery has ruled that TowerBrook Capital Partners LP and Ascension Health Alliance must face a stockholder claim over the $8.9 billion take-private of R1 RCM Inc., according to Law360.
- • The court found that the TowerBrook-Ascension joint investment vehicle qualified as a controlling stockholder despite holding less than one-third of R1 RCM's voting shares.
- • The ruling keeps the claim alive at the pleading stage, exposing the buyers to litigation over the deal's governance and fiduciary obligations.
Summary
The Delaware Court of Chancery has ruled that private equity firm TowerBrook Capital Partners LP and health system Ascension Health Alliance must face a stockholder claim challenging the $8.9 billion take-private of R1 RCM Inc., a healthcare revenue management company, according to a report published by Law360 on October 29, 2026.
The court determined that the joint investment vehicle formed by TowerBrook and Ascension qualified as a controlling stockholder of R1 RCM. Notably, the vehicle owned less than one-third of the company's voting shares, yet the court found that its position was sufficient to confer controlling-stockholder status. That finding is significant because controlling stockholders in Delaware owe fiduciary duties to minority shareholders, and a determination of control typically subjects a transaction to heightened judicial scrutiny.
Because the court declined to dismiss the claim, the plaintiffs' challenge to the take-private proceeds, and the defendants face continued litigation rather than an early exit. The Law360 report is limited to the court's ruling and the threshold control finding; further details on the specific allegations, the damages sought, and the defendants' responses were not available in the source material reviewed.
The court determined that the joint investment vehicle formed by TowerBrook and Ascension qualified as a controlling stockholder of R1 RCM. Notably, the vehicle owned less than one-third of the company's voting shares, yet the court found that its position was sufficient to confer controlling-stockholder status. That finding is significant because controlling stockholders in Delaware owe fiduciary duties to minority shareholders, and a determination of control typically subjects a transaction to heightened judicial scrutiny.
Because the court declined to dismiss the claim, the plaintiffs' challenge to the take-private proceeds, and the defendants face continued litigation rather than an early exit. The Law360 report is limited to the court's ruling and the threshold control finding; further details on the specific allegations, the damages sought, and the defendants' responses were not available in the source material reviewed.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.